Acute and chronic effects of glucocorticoids on carbohydrate metabolism in subjects with inflammatory rheumatologic disease.

Not Applicable

Suspended

• Conditions: inflammatory rheumatologic disease; Metabolic and Endocrine - Other metabolic disorders; Cardiovascular - Other cardiovascular diseases; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12610000409077
• Lead Sponsor: Dr Morton Burt

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-05-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Suspended
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Inflammatory rheumatologic disease
Group 1 - not currently on glucocorticoid therapy and have not been on glucocorticoid therapy for at least the last 6 months
Group 2 - currently on glucocorticoid therapy (4-10mg/day), and have been on this therapy for at least 6 months

Exclusion Criteria

Diagnosis of diabetes mellitus;
Inability to provide informed consent;
Medications which significantly affect carbohydrate metabolism;
New York Heart Association (NYHA) class IV cardiac failure;
Severe renal or hepatic disease;
Inability to lie flat for 6 hours

Study & Design

• Study Type: Interventional
• Study Design: Not specified